Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (361-370 of 975) with videos related to

Pageof 98
Sort By:
Virchows Archiv : an International Journal of Pathology|November 29, 2018
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladderPhilipp Erben, Danijel Sikic, Ralph M Wirtz, et al.
European Urology|December 8, 2004
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancerRobert Stoehr, Sabrina Zietz, Maximilian Burger, et al.
European Urology|June 10, 2006
Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancerMaximilian Burger, Sarah J Burger, Stefan Denzinger, et al.
The Journal of Investigative Dermatology|June 17, 2006
High frequency of FGFR3 mutations in adenoid seborrheic keratosesChristian Hafner, Johanna M M van Oers, Arndt Hartmann, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2017
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patientsJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
The Journal of Clinical Investigation|July 15, 2006
Mosaicism of activating FGFR3 mutations in human skin causes epidermal neviChristian Hafner, Johanna M M van Oers, Thomas Vogt, et al.
International Journal of Clinical and Experimental Pathology|July 8, 2010
Expression of fatty acid synthase in nonalcoholic fatty liver diseaseChristoph Dorn, Marc-Oliver Riener, Georgi Kirovski, et al.
Anticancer Research|July 31, 2012
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancerSebastian Rogenhofer, Jörg Ellinger, Philip Kahl, et al.
Geburtshilfe Und Frauenheilkunde|April 7, 2025
Pathologically Tumor-free Resection Margin Distance as a Surrogate Parameter in Primary Vulvar Squamous Cell Cancer: Analysis of a Large Two-Center Patient CohortEva Balog, Frederik A Stuebs, Ronald Berndt, et al.
Pageof 98

Showing results (361-370 of 975) with videos related to

Sort By:
Pageof 98
Virchows Archiv : an International Journal of Pathology|November 29, 2018
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladderPhilipp Erben, Danijel Sikic, Ralph M Wirtz, et al.
European Urology|December 8, 2004
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancerRobert Stoehr, Sabrina Zietz, Maximilian Burger, et al.
European Urology|June 10, 2006
Elevated microsatellite instability at selected tetranucleotide repeats does not correlate with clinicopathologic features of bladder cancerMaximilian Burger, Sarah J Burger, Stefan Denzinger, et al.
The Journal of Investigative Dermatology|June 17, 2006
High frequency of FGFR3 mutations in adenoid seborrheic keratosesChristian Hafner, Johanna M M van Oers, Arndt Hartmann, et al.
The American Journal of Surgical Pathology|January 13, 2005
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlationGad Singer, Robert Stöhr, Leslie Cope, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2017
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patientsJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
The Journal of Clinical Investigation|July 15, 2006
Mosaicism of activating FGFR3 mutations in human skin causes epidermal neviChristian Hafner, Johanna M M van Oers, Thomas Vogt, et al.
International Journal of Clinical and Experimental Pathology|July 8, 2010
Expression of fatty acid synthase in nonalcoholic fatty liver diseaseChristoph Dorn, Marc-Oliver Riener, Georgi Kirovski, et al.
Anticancer Research|July 31, 2012
Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancerSebastian Rogenhofer, Jörg Ellinger, Philip Kahl, et al.
Geburtshilfe Und Frauenheilkunde|April 7, 2025
Pathologically Tumor-free Resection Margin Distance as a Surrogate Parameter in Primary Vulvar Squamous Cell Cancer: Analysis of a Large Two-Center Patient CohortEva Balog, Frederik A Stuebs, Ronald Berndt, et al.
Pageof 98